Is Cross Country Healthcare (CCRN) a High Growth Potential Stock?
- Oops!Something went wrong.Please try again later.
Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund delivered a return of -3.09% net of fees, underperforming the -2.19% return of the Russell 2000 Index. Sector allocation contributed positively to the fund’s performance in the quarter, while stock selection detracted. In addition, you can check the top 5 holdings of the fund to know its best picks in 2022.
Aristotle Capital highlighted stocks like Cross Country Healthcare, Inc. (NASDAQ:CCRN) in its Q3 2022 investor letter. Headquartered in Boca Raton, Florida, Cross Country Healthcare, Inc. (NASDAQ:CCRN) provides consultation services for healthcare clients. On November 23, 2022, Cross Country Healthcare, Inc. (NASDAQ:CCRN) stock closed at $35.21 per share. One-month return of Cross Country Healthcare, Inc. (NASDAQ:CCRN) was -3.16%, and its shares gained 24.55% of their value over the last 52 weeks. Cross Country Healthcare, Inc. (NASDAQ:CCRN) has a market capitalization of $1.313 billion.
Aristotle Capital made the following comment about Cross Country Healthcare, Inc. (NASDAQ:CCRN) in its Q3 2022 investor letter:
"Cross Country Healthcare, Inc. (NASDAQ:CCRN), a workforce solutions and healthcare staffing company, appreciated amid a favorable demand and pricing environment along with strengthening investor sentiment following the company’s upbeat investor day. We maintain a position, as we believe management’s recent investments in technology along with favorable industry supply-demand dynamics have the potential to drive further value for shareholders in periods to come"
Tyler Olson/Shutterstock.com
Cross Country Healthcare, Inc. (NASDAQ:CCRN) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 20 hedge fund portfolios held Cross Country Healthcare, Inc. (NASDAQ:CCRN) at the end of the third quarter, which was 15 in the previous quarter.
We discussed Cross Country Healthcare, Inc. (NASDAQ:CCRN) in another article and shared Rhizome Partners' views on the company. In addition, please check out our hedge fund investor letters Q3 2022 page for more investor letters from hedge funds and other leading investors.
Suggested Articles:
Disclosure: None. This article is originally published at Insider Monkey.
